Wednesday, 16 Oct 2019

You are here

Daniel Lovell, MD: abatacept in JIA

Dr. Daniel Lovell, a pediatric rheumatologist from the University of Cincinnati/Cincinnati Children's Hospital Medical Center discusses a phase-4 study looking at the effectiveness and safety of abatacept in kids with JIA.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Arthur Kavanaugh: Safety and...

07 Nov 2017

RheumNow Podcast – Late Breaking...

21 Jun 2019

Dr. Janet Pope at EULAR 2018 on...

20 Jun 2018

Dr. Peter Lipsky - 1 Million #Gout...

21 Jun 2019

Dr. George Martin: practical tips on...

02 Mar 2016

RNL Intro - Dr. Lisa Sammaritano on...

01 Apr 2019

Dr. Rachel Tate: Ultrasound Education

08 Nov 2017

Dr. Sergio Schwartzman: uveitis

02 Mar 2016

Dr. Ken Saag: Update on Gout Therapy

07 Nov 2017

Drs. Jack Cush, Arthur Kavanaugh and...

23 Oct 2018

Dr. Julio Gonzalez: Psoriatic Arthritis...

07 Nov 2017

RheumNow Live Preview with Dr. Elaine...

29 Apr 2019